Andrew M Thompson

4PUBLICATIONS
12CO-AUTHORS
Medical mycologyGene and molecular therapyBiologically active moleculesBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 01, 2023
Synthesis and Anti-Mycobacterium tuberculosis Activity of Imidazo[2,1-b][1,3]oxazine Derivatives against Multidrug-Resistant Strains.

Guilherme F S Fernandes, Karyn F Manieri, Andressa F Bonjorno

|May 25, 2022
Tuberculosis Drug Discovery: Challenges and New Horizons.

Guilherme F S Fernandes, Andrew M Thompson, Daniele Castagnolo

|Feb 21, 2018
Development of (6 R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5 H-imidazo[2,1- b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis.

Andrew M Thompson, Patrick D O'Connor, Andrew J Marshall

|May 02, 2017
7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral Leishmaniasis.

Andrew M Thompson, Patrick D O'Connor, Andrew J Marshall

Pageof 1

Frequent Collaborators

3 joint publications

William A Denny

2 joint publications

Guilherme F S Fernandes

1 joint publications

Daniele Castagnolo

1 joint publications

Jean L Dos Santos